AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
254.76
-6.31 (-2.42%)
At close: Jul 6, 2026, 4:00 PM EDT
258.20
+3.44 (1.35%)
Pre-market: Jul 7, 2026, 7:36 AM EDT

AbbVie Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
450,108403,970313,686273,668285,917239,433
Market Cap Growth
37.38%28.78%14.62%-4.28%19.41%26.59%
Enterprise Value
513,629466,251375,314320,274339,992306,315
Last Close Price
254.76228.49177.70154.97161.61135.40
PE Ratio
125.4996.8274.3556.9724.3820.99
Forward PE
17.4016.5714.8113.9612.7210.04
PEG Ratio
1.371.091.6858.43-2.03
PS Ratio
7.176.615.575.044.934.26
PB Ratio
--123.5494.3426.4216.5715.54
P/FCF Ratio
22.5322.6717.5912.4011.7910.89
P/OCF Ratio
21.2121.2316.6811.9811.4610.51
EV/Sales Ratio
8.187.626.665.905.865.45
EV/EBITDA Ratio
17.1720.0821.4214.9312.7911.58
EV/EBIT Ratio
23.4830.9341.0825.1118.7717.09
EV/FCF Ratio
25.7126.1721.0514.5214.0213.93
Debt / Equity Ratio
-9.76-19.0317.945.023.424.16
Debt / EBITDA Ratio
3.122.913.832.772.382.90
Debt / FCF Ratio
3.653.793.772.692.613.49
Net Debt / Equity Ratio
-9.53-19.0318.524.503.134.34
Net Debt / EBITDA Ratio
2.722.683.522.172.032.53
Net Debt / FCF Ratio
3.183.493.452.112.233.04
Asset Turnover
0.460.450.420.400.410.38
Inventory Turnover
3.683.994.085.325.195.42
Quick Ratio
0.520.410.430.630.690.56
Current Ratio
0.800.670.660.870.960.79
Return on Equity (ROE)
-74.00%6225.00%62.29%35.20%72.40%80.95%
Return on Assets (ROA)
6.91%7.19%7.81%7.27%11.16%10.73%
Return on Invested Capital (ROIC)
10.10%12.43%17.29%15.50%20.73%18.43%
Return on Capital Employed (ROCE)
16.57%16.12%9.45%12.38%16.43%15.37%
Earnings Yield
0.80%1.03%1.34%1.76%4.10%4.76%
FCF Yield
4.44%4.41%5.68%8.06%8.48%9.18%
Dividend Yield
2.72%2.88%3.51%3.85%3.51%3.86%
Payout Ratio
336.44%275.84%257.71%216.72%84.85%80.24%
Buyback Yield / Dilution
-0.04%0.00%0.00%0.28%-0.06%-6.22%
Total Shareholder Return
2.67%2.88%3.51%4.13%3.45%-2.35%
SEC Filings: 10-K · 10-Q